New approaches in the pharmacological treatment of stress urinary incontinence
|
|
- Ethelbert Stewart
- 5 years ago
- Views:
Transcription
1 International Journal of Gynecology and Obstetrics 86 Suppl. 1 (2004) S1 S5 New approaches in the pharmacological treatment of stress urinary incontinence Keywords: Stress urinary incontinence; Epidemiology; Diagnosis; Therapy; Duloxetine 1. Introduction Stress urinary incontinence (SUI) is a common condition among women of all ages which leads to significant bother and has a negative impact on the quality of life (QoL) of the affected individuals and their families w1,2x. The bothersome symptoms of SUI may restrict physical activities and impair social and sexual activities and relationships. However, many women with SUI suffer in silence w3,4x. This is probably due to the fact that patients experience SUI as a highly embarrassing condition and are ashamed to admit that they are suffering from it. In addition, many patients may attribute the symptoms to aging andyor are afraid of surgery and believe that this is the only treatment option available. Lack of a globally developed or widely approved pharmacological therapy that may fill the current gap in treatment options between conservative treatment on one hand and surgery on the other may also contribute to this barrier to seek treatment. In this regard, healthcare professionals should encourage help-seeking behavior of women suffering from SUI and educate them on the available treatment options. The purpose of the present supplement is, therefore, to review the epidemiology, etiology and management of women presenting with SUI symptoms, with a special focus on new pharmacological treatment approaches. 2. Definitions of SUI The International Continence Society (ICS) has defined SUI at four different levels: as a symptom, sign, urodynamic observation and condition w5x. The symptom of SUI is defined as the patient s complaint of involuntary leakage of urine on effort or exertion, or on sneezing or coughing. The sign of SUI is defined as the observation of involuntary leakage from the urethra, synchronous with exertionyeffort, or sneezing or coughing. This can be objectively demonstrated by the physician during for instance a cough or pad stress test. The urodynamic observation of SUI is the involuntary leakage of urine during increased abdominal pressure in the absence of involuntary detrusor contractions (IDCs) during filling cystometry. The condition of SUI is defined by the presence of urodynamic observations associated with characteristic symptoms or signs of SUI. 3. The prevalence of SUI In this supplement, Oscar Contreras Ortiz reviews the current literature on the prevalence of urinary incontinence (UI) according to the three main types of UI: SUI, urge urinary incontinence (UUI) and mixed urinary incontinence (MUI) w6x. It appears that UI is approximately two to four times more prevalent in women than men and that in women the reported prevalence of UI varies considerably across studies (range 11 72%) w6x. In a recent literature review of 35 worldwide studies surveying approximately people, the author and his co-workers confirmed that UI is almost three times more common in women than in men and that in women the prevalence /03/$ International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved. doi: /j.ijgo
2 S2 type of incontinence (occurring in 50% of all incontinent women) followed by MUI (36%) and UUI (11%) w1x. The literature review confirmed that most women (82%) suffer from SUI with or without additional urge symptoms (Fig. 1) w4x. It appears that whereas SUI is the most prevalent type in young and middle-aged women, MUI becomes more prevalent in older women due to the fact that the occurrence of urge symptoms increases with age (Fig. 2) w1,6x. 4. Impact of SUI on QoL Fig. 1. Prevalence of UI by type of incontinence in women w4x. Four percent of the incontinent women had another type of incontinence other than SUI, MUI or UUI. ranges between 5 and 58% w4x. This wide range in prevalence rates is probably mainly due to different definitions of UI (from any loss of urine in a 12-month period to two or more wetting episodes in the past month ), different populations studied (e.g. different age groups or different settings (community-based vs. institutionalized)) andyor different methods of data collection (posted questionnaires vs. personal interviews). The literature review, however, shows that on average one in every four women has UI w4x. This was confirmed in the EPINCONT study involving women living in a county in Norway w1x. This study also showed that SUI is the most prevalent Approximately half of all women with UI are slightly bothered and one third moderately to severely bothered w1,2,6x. Despite this, only one in every four incontinent women seeks medical advice w3,4,6x and often there is a delay of one year or longer before they first consult a physician w3,6,7x. In the studies included in the literature review, 50% of patients reported that UI affected their QoL at least slightly but 77% of these patients did not seek help w3x. 5. Causes of SUI There are two main causes of SUI: bladder neckyurethral hypermobility and intrinsic sphincter deficiency (ISD). In many women, SUI is caused by a combination of both. Due to weakening of the extrinsic support of the proximal urethra, the Fig. 2. Prevalence of UI by type of incontinence and by age in women. Reproduced by permission of Elsevier from Ref. w4x.
3 S3 Table 1 Currently available pharmacological therapies for SUI w11x Off-label used On-label used in some Side effects countries Estrogens TCAs Imipramine Increased risk of cardiovascular disease and increased risk of breast and endometrial cancer w20x Dry mouth, constipation, retention, orthostatic hypotension, falls b2-ar agonists Tremor, tachycardia, headache Clenbuterol: Japan a1-ar agonists Elevated blood pressure, palpitations, Midodrine hydrochloride: Portugal abnormal cardiac rhythm PPA: Finland Removed from the US market due to increased risk of hemorrhagic stroke bladder neck andyor urethra descends outside the intra-abdominal cavity during stress activities (exercising, coughing, sneezing). As a consequence the urethra cannot sufficiently compress and the increased intra-abdominal pressure overrides intra-urethral pressure which leads to urine leakage. In patients with ISD, the intrinsic urethral sphincter mechanism and its nerve supply is damaged and can, therefore, not maintain an adequate urethral tone when stress activities increase intraabdominal pressure. 6. Risk factors for the development of SUI The etiology of (S)UI is still poorly understood. The available evidence on potential risk factors for the development of (S)UI such as age, pregnancyychildbirthyparity, obesity, smoking, chronic cough, constipation, menopauseyestrogen deficiency and previous hysterectomy has also been reviewed by Oscar Contreras Ortiz w6x. It appears that the most studied risk factors with sufficient proof are age, pregnancyychildbirthyparity and obesity. 7. Initial management of SUI As indicated by Peter Dwyer in this supplement, a major first step in the diagnosis and management of women presenting with incontinence is to distinguish between SUI and UUI as both types of incontinence require different treatment w8x. This differentiation is in first instance based on the patient s symptomsycomplaints. Whereas incontinence associated with vigorous exercise, coughing, sneezing or laughing suggests the presence of SUI, incontinence accompanied or immediately preceded by urgency (e.g. during hand washing or key in the door) is suggestive of UUI. A bladder diary may be of help in assessing the type and frequency of symptoms as well as the circumstances causing urine leakage. A diagnosis of SUI becomes more likely when urine leakage can be observed during a cough andyor pad stress test; the weight of the pad is, moreover, indicative for the amountyseverity of leakage. If SUI is confirmed by these methods, it does not seem to be essential to initially perform urodynamic studies for demonstrating urodynamic evidence of SUI. This is because these are invasive and the correlation between urodynamic findings and the symptoms of UI is in general poor, in particular in patients with MUI symptoms w8 10x. It is instead proposed to first test whether the patient responds to life style interventions (e.g. fluid management, weight loss, stop smoking), non-invasive conservative treatment such as pelvic floor muscle training (PFMT) andyor to pharmacological therapy for SUI. The major drawbacks of PFMT are the facts that it takes some time before the patient may experience the benefit and that in many patients compliance decreases over time. Unfortunately there are currently no globally developed or widely
4 S4 approved pharmacological treatments available (see Table 1) w11x. Some drugs are used off-label wi.e. a1-adrenoceptor (AR) agonists, tricyclic antidepressants (TCAs) and estrogensx, but with no evidence of efficacy from randomized, controlled trials (RCTs). Furthermore, they can be associated with significant and sometimes serious side effects such as hypertension, cardiac arrhythmias and hemorrhagic stroke with the non-selective a-ar agonist phenylpropanolamine (PPA) and increased risk of cardiovascular disease and breast and endometrial cancer with estrogens. 8. Specialized management of SUI Patients with SUI who fail conservative andyor pharmacological treatment or patients with severe SUI in whom surgery is planned, should first undergo urodynamic studies. If during bladder filling increased intra-abdominal pressure (e.g. due to coughing) is not accompanied by IDCs, urodynamic stress incontinence is confirmed and one can proceed with surgery. There are three main types of surgical interventions available with increasing rates of invasiveness and increasing rates of associated effectiveness and complications (such as de novo detrusor overactivity and voiding dysfunction): urethral bulking agents (or injectables), suburethral sling procedures and colposuspensions. Urethral bulking agents are most suitable for patients with ISD; the glutaraldehyde cross-linked bovine (GAX)-collagen has been studied most intensively w12x. Of the sub-urethral sling procedures, the classical slings are indicated for patients with ISD and the less invasive tension-free vaginal tape (TVT) for patients with hypermobility w12x. Colposuspensions are still considered to be the gold standard surgical intervention for patients with hypermobility although high efficacy rates are also accompanied with increased invasiveness and complications rates. There is currently lack of consensus as to which surgical procedure is the best. This is due to the facts that the scientific evidence is weak as most data are derived from case series and that the methodological quality of many studies is poor with no consistency in efficacy and safety variables and definition of outcomes (e.g. different definitions of cure or success) used w13,14x. This makes comparison of the results from different studies with different surgical procedures very difficult. For more information on European guidelines for the initial diagnosis and treatment of UI in women, with emphasis on the International Consultation on Incontinence guidelines, the paper by Lars Viktrup and colleagues in this supplement provides an excellent overview w15x. 9. New approaches in pharmacological treatment It is clear that there is a need for a globally developed and widely approved pharmacological treatment option that has been proven to be effective and safe in well-designed, adequately powered RCTs. A pharmacological treatment designed to fill the treatment gap between PFMT on one hand (which requires long-term exercising and a highly motivated patient) and surgery (which is invasive and associated with intra-and post-operative complications for which patients are often afraid) on the other hand. One of such treatments may be the potent and balanced dual serotonin and norepinephrine (or noradrenaline) reuptake inhibitor (SNRI) duloxetine w16x. As outlined in this supplement by Karl Thor w17x, the neurotransmitters serotonin and norepinephrine are believed to potentiate the effect of glutamate in Onuf s nucleus in the sacral spinal cord on stimulating the efferent activity of the pudendal nerve during bladder filling. This causes stimulation of nicotinic receptors in the striated urethral sphincter (or rhabdosphincter) and increased contraction of this sphincter thereby overriding increased intra-abdominal pressure during stress activities. By inhibiting the reuptake of serotonin and norepinephrine, duloxetine increases the concentration of these two neurotransmitters in the synaptic cleft in the CNS. It has been shown that this increases bladder capacity and induces an eight-fold increase in electromyography (i.e. rhabdosphincter) activity in an in vivo cat irritated bladder model w17,18x. That these effects are beneficial in women with SUI is demonstrated in the review in this supplement by Kate Moore on duloxetine s efficacy and safety in RCTs w19x. In
5 S5 phase two and phase three clinical trials almost 2000 patients were treated with placebo or duloxetine 80 mgyday (40 mg twice daily) for 12 weeks. Duloxetine provided a very fast (maximal effects within 1 2 weeks) increase in incontinence episode frequency and incontinence-related QoL, independent of incontinence severity at baseline. This was associated with an increase in mean time between voids and these effects were highly appreciated by the patients. The most common adverse event was nausea but this is experienced soon after start of therapy (usually within days), of mild to moderate intensity and transient as it resolves in most patients within 1 4 weeks. It, therefore, seems that duloxetine is a very promising new pharmacological treatment approach for women suffering from SUI. References w1x Hannestad YS, Rortveit G, Sandvik H, Hannestad YS. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. J Clin Epidemiol 2000;53: w2x Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol 2003;189: w3x Kinchen KS, Burgio K, Diokno AC, Fultz NH, Bump R, Obenchain R. Factors associated with women s decisions to seek treatment for urinary incontinence. J Women s Health 2003;12: w4x Minassian VA, Drutz HP, Al-Badr A. Urinary incontinence as a worldwide problem. Int J Gynecol Obstet 2003;82: w5x Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmstem U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21: w6x Contreras Ortiz O. Stress urinary incontinence in the gynecological practice. Int J Gynecol Obstet 2004;86;(Suppl 1)S6 S16. w7x Norton PA, MacDonald LD, Sedgwick PM, Stanton SL. Distress and delay associated with urinary incontinence, frequency, and urgency in women. Br Med J 1988;297: w8x Dwyer P. Differentiating stress urinary incontinence from urge urinary incontinence. Int J Gynecol Obstet 2004;86:(Suppl 1)S17 S24. w9x Sandvik H, Hunskaar S, Vanvik A, Bratt H, Seim A, Hermstad R. Diagnostic classification of female urinary incontinence: an epidemiological survey corrected for validity. J Clin Epidemiol 1995;48: w10x Weidner AC, Myers ER, Visco AG, Cundiff GW, Bump RC. Which women with stress incontinence require urodynamic evaluation? Am J Obstet Gynecol 2001; 184: w11x Viktrup L, Bump RC. Pharmacological agents used for the treatment of stress urinary incontinence in women. Curr Med Res Opin 2003;19: w12x Pesce F. Current management of stress urinary incontinence. BJU Int 2004;98(Suppl 1) w13x Hilton P. Trials of surgery for stress incontinence thoughts on the Humpty Dumpty principle. Br J Obstet Gynecol 2002;109: w14x Black NA, Downs SH. The effectiveness of surgery for stress incontinence in women a systematic review. Br J Urol 1996;78: w15x Viktrup L, Summers KH, Dennett SL. Clinical practice guidelines for the initial management of urinary incontinence in women: a European-focused review. Int J Gynecol Obstet 2004;86:(Suppl 1)S25 S37. w16x Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL. Comparative affinity of duloxetine and venlafaxine for serotonin and norepineprine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001;25: w17x Thor K. Targeting serotonin and norepinephrine receptors in stress urinary incontinence. Int J Gynecol Obstet 2004;86:(Suppl 1)S38 S52. w18x Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 1995;274: w19x Moore K. Duloxetine: a new approach for treating stress urinary incontinence. Int J Gynecol Obstet 2004;86:(Suppl 1)S53 S62. w20x Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women (Cochrane review). In: The Cochrane Library, Issue 2, Oxford: Update Software. The Guest Editor: H. Drutz * address: hdrutz@mtsinai.on.ca University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada *Tel.: q ; fax: q
Duloxetine in women awaiting surgery
DOI: 1.1111/j.1471-528.6.879.x www.blackwellpublishing.com/bjog Review article H Drutz Ontario Power Generation Building, Toronto, Ontario, Canada Correspondence: Prof. Dr H Drutz, Mount Sinai Hospital,
More informationNormal micturition involves complex
NEW TARGET FOR INTERVENTION: THE NEUROUROLOGY CONNECTION * Donald R. Ostergard, MD, FACOG ABSTRACT Urine storage and release are under the control of the parasympathetic, sympathetic, and somatic nervous
More informationUrinary incontinence (UI) affects as many
EXPLORING NEW HORIZONS IN STRESS INCONTINENCE: THE NEUROUROLOGY CONNECTION W. Glenn Hurt, MD* ABSTRACT As many as one-third of women are affected by urinary incontinence, the most common of which being
More informationCompassionate and effective management
IMPACT OF STRESS URINARY INCONTINENCE ON QUALITY OF LIFE * Paul Abrams, MD, FRCS ABSTRACT Evaluating the impact of stress urinary incontinence (SUI) on quality of life (QOL) is of paramount importance,
More informationObjectives. Prevalence of Urinary Incontinence URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS
URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS Lisa S Pair, MSN, CRNP Division of Urogynecology and Pelvic Reconstructive Surgery Department of Obstetrics and Gynecology University of Alabama
More informationManagement of Urinary Incontinence in Older Women. Dr. Cecilia Cheon Department of Obs. & Gyn. Queen Elizabeth Hospital
Management of Urinary Incontinence in Older Women Dr. Cecilia Cheon Department of Obs. & Gyn. Queen Elizabeth Hospital Epidemiology Causes Investigation Treatment Conclusion Elderly Women High prevalence
More informationDuloxetine, a Serotonin and Noradrenaline Reuptake Inhibitor (SNRI) for the Treatment of Stress Urinary Incontinence: A Systematic Review
european urology 51 (2007) 67 74 available at www.sciencedirect.com journal homepage: www.europeanurology.com Review Female Urology Incontinence Duloxetine, a Serotonin and Noradrenaline Reuptake Inhibitor
More informationURINARY INCONTINENCE. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara Definition The involuntary loss of urine May denote a symptom, a sign or a condition Symptom the
More informationThe Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence
european urology supplements 5 (2006) 849 853 available at www.sciencedirect.com journal homepage: www.europeanurology.com The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence Stefano
More informationManagement of Female Stress Incontinence
Management of Female Stress Incontinence Dr. Arvind Goyal Associate Professor (Urology& Renal Transplant) Dayanand Medical College & Hospital, Ludhiana, Punjab, India Stress Incontinence Involuntary loss
More informationUpdate on duloxetine for the management of stress urinary incontinence
REVIEW Update on duloxetine for the management of stress urinary incontinence Maya Basu Jonathan RA Duckett Department of Obstetrics and Gynaecology, Medway Maritime Hospital, Gillingham, Kent, UK Correspondence:
More informationStress Incontinence. Susannah Elvy Urogynaecology CNS
Stress Incontinence Susannah Elvy Urogynaecology CNS Definitions Prevalence Assessment Investigation Treatment Surgery Men International Continence Society define as the complaint of any involuntary leakage
More informationUrinary Incontinence. Lora Keeling and Byron Neale
Urinary Incontinence Lora Keeling and Byron Neale Not life threatening. Introduction But can have a huge impact on quality of life. Two main types of urinary incontinence (UI). Stress UI leakage on effort,
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Urinary incontinence: the management of urinary incontinence in women
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary incontinence: the management of urinary incontinence in women 1.1 Short title Urinary incontinence 2 Background a) The National
More informationInternational Federation of Gynecology and Obstetrics
International Federation of Gynecology and Obstetrics COMMITTEE FOR UROGYNAECOLOGY AND PELVIC FLOOR MEMBER: TSUNG-HSIEN (CHARLES) SU, CHAIR (TAIWAN) DAVID RICHMOND, CO-CHAIR (UK) CHITTARANJAN PURANDARE,
More informationNonsurgical treatment remains a major PROCEEDINGS NEW ADVANCES IN THE NONSURGICAL MANAGEMENT OF STRESS URINARY INCONTINENCE *
NEW ADVANCES IN THE NONSURGICAL MANAGEMENT OF STRESS URINARY INCONTINENCE * Nicolette S. Horbach, MD, FACOG ABSTRACT Most patients with stress urinary incontinence (SUI) warrant a trial of nonsurgical
More informationUrinary Incontinence in Women: Never an Acceptable Consequence of Aging
Urinary Incontinence in Women: Never an Acceptable Consequence of Aging Catherine A. Matthews, MD Associate Professor Chief, Urogynecology and Pelvic Reconstructive Surgery University of North Carolina,
More informationOperative Approach to Stress Incontinence. Goals of presentation. Preoperative evaluation: Urodynamic Testing? Michelle Y. Morrill, M.D.
Operative Approach to Stress Incontinence Goals of presentation Michelle Y. Morrill, M.D. Director of Urogynecology The Permanente Medical Group Kaiser, San Francisco Review preoperative care & evaluation
More informationUrodynamics in women. Aims of Urodynamics in women. Why do Urodynamics?
Urodynamics in women Chendrimada Madhu MD, MA, MRCOG Subspecialty Trainee in Urogynaecology Southmead Hospital 2013 Aims of Urodynamics in women n Confirmation of incontinence and its cause n Definition
More informationUrogynaecology. Colm McAlinden
Urogynaecology Colm McAlinden Definitions Urinary incontinence compliant of any involuntary leakage of urine with many different causes Two main types: Stress Urge Definitions Nocturia: More than a single
More informationUrodynamic findings in women with insensible incontinence
bs_bs_banner International Journal of Urology (2013) 20, 429 433 doi: 10.1111/j.1442-2042.2012.03146.x Original Article: Clinical Investigation Urodynamic findings in women with insensible Benjamin M Brucker,
More informationNeurourology, especially the video urodynamic
NEUROUROLOGIC FINDINGS WITH APPLICABILITY TO INCONTINENCE AND URETHRAL FUNCTION * Edward J. McGuire, MD ABSTRACT Neurourology is applicable to urinary incontinence and obstructive uropathy in the general
More informationThe Burden of Stress Urinary Incontinence
European Urology Supplements European Urology Supplements 4 (2005) 5 10 The Burden of Stress Urinary Incontinence Gunnar Lose* Department of Obstetrics and Gynaecology, Copenhagen University, Glostrup
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary incontinence in women: the management of urinary incontinence in women 1.1 Short title Urinary incontinence in women
More informationDuloxetine in the treatment of stress urinary incontinence
REVIEW Duloxetine in the treatment of stress urinary incontinence Wolfgang H Jost 1 Parvaneh Marsalek 2 1 Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany; 2 Lilly Deutschland
More informationJohn Laughlin 4 th year Cardiff University Medical Student
John Laughlin 4 th year Cardiff University Medical Student Prolapse/incontinence You need to know: Pelvic floor anatomy in relation to uterovaginal support and continence The classification of uterovaginal
More informationResolution of urge urinary incontinence with midurethral sling surgery in patients with mixed incontinence and low-pressure urethra
Gynecol Surg (2012) 9:427 432 DOI 10.1007/s10397-012-0735-7 ORIGINAL ARTICLE Resolution of urge urinary incontinence with midurethral sling surgery in patients with mixed incontinence and low-pressure
More informationDiagnosis and Treatment of Urinary Incontinence. Urinary Incontinence
Diagnosis and Treatment of Urinary Incontinence Leslee L. Subak, MD Professor Obstetrics, Gynecology & RS Epidemiology, Urology University of California, San Francisco Urinary Incontinence Common - 25%
More informationProlapse and Urogynae Incontinence. Lucy Tiffin and Hannah Wheldon-Holmes
Prolapse and Urogynae Incontinence Lucy Tiffin and Hannah Wheldon-Holmes 66 year old woman with incontinence PC: 7 year Hx of urgency, frequency, nocturia (incl. incontinence at night), and stress incontinence
More informationPRE-OPERATIVE URODYNAMIC
PRE-OPERATIVE URODYNAMIC STUDIES: IS THERE VALUE IN PREDICTING POST-OPERATIVE STRESS URINARY INCONTINENCE IN WOMEN UNDERGOING PROLAPSE SURGERY? Dr K Janse van Rensburg Dr JA van Rensburg INTRODUCTION POP
More informationTreatment Outcomes of Tension-free Vaginal Tape Insertion
Are the Treatment Outcomes of Tension-free Vaginal Tape Insertion the Same for Patients with Stress Urinary Incontinence with or without Intrinsic Sphincter Deficiency? A Retrospective Study in Hong Kong
More informationSummary. Neuro-urodynamics. The bladder cycle. and voiding. 14/12/2015. Neural control of the LUT Initial assessment Urodynamics
Neuro-urodynamics Summary Neural control of the LUT Initial assessment Urodynamics Marcus Drake, Bristol Urological Institute SAFETY FIRST; renal failure, dysreflexia, latex allergy SYMPTOMS SECOND; storage,
More informationThe development of a questionnaire to measure the severity of symptoms and the quality of life before and after surgery for stress incontinence
BJOG: an International Journal of Obstetrics and Gynaecology November 2003, Vol. 110, pp. 983 988 The development of a questionnaire to measure the severity of symptoms and the quality of life before and
More informationVarious Types. Ralph Boling, DO, FACOG
Various Types Ralph Boling, DO, FACOG The goal of this lecture is to increase assessment and treatment abilities for physicians managing urinary incontinence (UI) patients. 1. Effectively communicate with
More informationPREVENTING URINARY INCONTINENCE through PELVIC FLOOR REHABILITATION in DISABLED ELDERLY
PREVENTING URINARY INCONTINENCE through PELVIC FLOOR REHABILITATION in DISABLED ELDERLY Paolo DI BENEDETTO Lecturer, Tor Vergata University, Rome, Italy Former Director of Rehabilitation Department Institute
More informationUrinary incontinence Pathophysiology and management outline
THEME URINARY Incontinence Stanley K Santiagu MBBCh, is resident medical officer, Department of Urology, Port Macquarie Base Hospital, Port Macquarie, New South Wales. stanleyk@ hotmail.com Mohan Arianayagam
More informationInterventional procedures guidance Published: 12 October 2016 nice.org.uk/guidance/ipg566
Single-incision short sling mesh insertion for stress urinary incontinence in women Interventional procedures guidance Published: 12 October 2016 nice.org.uk/guidance/ipg566 Your responsibility This guidance
More informationPrevalence and risk factors for pelvic floor symptoms in women in rural El Salvador
Int Urogynecol J (2007) 18:1065 1069 DOI 10.1007/s00192-006-0292-6 ORIGINAL ARTICLE Prevalence and risk factors for pelvic floor symptoms in women in rural El Salvador Begüm Özel & Anne Marie Borchelt
More informationContent. Terminology Anatomy Aetiology Presentation Classification Management
Prolapse Content Terminology Anatomy Aetiology Presentation Classification Management Terminology Prolapse Descent of pelvic organs into the vagina Cystocele ant. vaginal wall involving bladder Uterine
More informationInitial management of stress urinary incontinence: pelvic floor muscle training and duloxetine
DOI: 1.1111/j.1471-528.6.878.x www.blackwellpublishing.com/bjog Review article Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine RM Freeman Urogynaecology Unit,
More informationUP DATE MANAGEMENT OF URINARY INCONTINENCE IN ADULT
UP DATE MANAGEMENT OF URINARY INCONTINENCE IN ADULT Yunizaf, MD Division of Urogynecology Department of Obstetrics and Gynecology School of Medicine, University of Indonesia/ Dr. Cipto Mangunkusumo Hospital
More informationAdvanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa
Advanced Care for Female Overactive Bladder & Urinary Incontinence Department of Urology Kaiser Permanente Santa Rosa Goals Participants will: Review normal urinary tract anatomy and function Understand
More informationBulkamid. Patient Information. Obstetrics & Gynaecology Department
Bulkamid Patient Information Obstetrics & Gynaecology Department Author ID: JD Leaflet Number: Gyn 050 Version: 5 Name of Leaflet: Bulkamid Date Produced: November 2017 Review Date: November 2019 Bulkamid
More informationURINARY INCONTINENCE
Center for Continence Care and Pelvic Medicine What is urinary incontinence? URINARY INCONTINENCE Urinary incontinence is the uncontrollable loss of urine. The amount of urine leaked can vary from only
More informationThis Special Report supplement
...INTRODUCTION... Overactive Bladder: Defining the Disease Alan J. Wein, MD This Special Report supplement to The American Journal of Managed Care features proceedings from the workshop, Overactive Bladder:
More information3/20/10. Prevalence of OAB Men: 16.0% Women: 16.9% Prevalence of OAB with incontinence (OAB wet) Men: 2.6% Women: 9.3% Dry. Population (millions) Wet
1 Prevalence of OAB Men: 16.0% Women: 16.9% Stewart WF, et al. World J Urol. 2003;20:327-336. Prevalence of OAB with incontinence (OAB wet) Men: 2.6% Women: 9.3% Stewart WF, et al. World J Urol. 2003;20:327-336.
More informationTraining a Wayward Bladder
D. James Ballard, PT, DPT, GCS The University of Utah, Dept. of Physical Therapy Training a Wayward Bladder Agenda 1. Discuss urinary incontinence 2. Review pelvic floor and lower urinary tract functional
More informationPrediction and prevention of stress urinary incontinence after prolapse surgery van der Ploeg, J.M.
UvA-DARE (Digital Academic Repository) Prediction and prevention of stress urinary incontinence after prolapse surgery van der Ploeg, J.M. Link to publication Citation for published version (APA): van
More informationManagement of OAB. Lynsey McHugh. Consultant Urological Surgeon. Lancashire Teaching Hospitals
Management of OAB Lynsey McHugh Consultant Urological Surgeon Lancashire Teaching Hospitals Summary Physiology Epidemiology Definitions NICE guidelines Evaluation Conservative management Medical management
More informationUrinary incontinence and overactive bladder in the non-institutionalized Portuguese population: national survey and methodological issues
Urinary incontinence and overactive bladder in the non-institutionalized Portuguese population: national survey and methodological issues Sofia Gonçalves Correia Porto 2008 Faculdade de Medicina da Universidade
More informationBill Landry BScPT, BScH, MCPA, CAFCI Family Physiotherapy Centre of London
Bill Landry BScPT, BScH, MCPA, CAFCI blandry@fpclondon.com Family Physiotherapy Centre of London Objectives To describe the scope of post-prostatectomy incontinence To describe what s been done To provide
More informationIncontinence; Lets talk about it. Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery
Incontinence; Lets talk about it Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery Select the most appropriate subtitle for this talk A: Bladders gone wild! B: There s no such thing
More informationEffects of Combined Pelvic Floor Muscle Exercises in Patient with Urinary Incontinence
MACROJOURNALS The Journal of MacroTrends in Health and Medicine Effects of Combined Pelvic Floor Muscle Exercises in Patient with Urinary Incontinence Vjollca Ndreu*, Fatjona Kamberi*, Enkeleda Sinaj*,
More informationREVIEW OF CAUSES, EVALUATION, AND TREATMENTS URINARY INCONTINENCE 101
REVIEW OF CAUSES, EVALUATION, AND TREATMENTS URINARY INCONTINENCE 101 March 5, 2014 Kevin E Miller, MD Department of Obstetrics and Gynecology University of Kansas School of Medicine- Wichita URINARY INCONTINENCE
More informationComparative Study of Solifenecin Alone Versus Solifenecin with Duloxetine in Patients of Overactive Bladder
International Journal of Scientific and Research Publications, Volume 3, Issue 1, January 2013 1 Comparative Study of Solifenecin Alone Versus Solifenecin with Duloxetine in Patients of Overactive Bladder
More informationUrethral pressure measurement in stress incontinence: does it help?
Int Urol Nephrol (2009) 41:491 495 DOI 10.1007/s11255-008-9506-9 UROLOGY - ORIGINAL PAPER Urethral pressure measurement in stress incontinence: does it help? Bassem S. Wadie Æ Ahmed S. El-Hefnawy Received:
More informationIncontinence: The silent scourge of the young and old. The International Continence Society has. In this article:
Focus on CME at the University of Toronto Incontinence: The silent scourge of the young and old By Sender Herschorn, BSc, MDCM, FRCSC In this article: 1. What is the workup for urinary incontinence? 2.
More informationUrinary Incontinence after Vaginal Delivery or Cesarean Section
The new england journal of medicine original article Urinary after Vaginal Delivery or Cesarean Section Guri Rortveit, M.D., Anne Kjersti Daltveit, Ph.D., Yngvild S. Hannestad, M.D., and Steinar Hunskaar,
More informationProlapse & Urogynaecology. Hester Mannion and Fabi Sica
Prolapse & Urogynaecology Hester Mannion and Fabi Sica Take home messages Prolapse and associated incontinence is very common It has a devastating effect on the QoL of the patient and their partner Strategies
More informationUrogynaecology. Introduction. M Gyhagen, a M Bullarbo, a,b TF Nielsen, a,b I Milsom a
DOI: 10.1111/1471-0528.12367 www.bjog.org Urogynaecology A comparison of the long-term consequences of vaginal delivery versus caesarean section on the prevalence, severity and bothersomeness of urinary
More informationOveractive Bladder: Diagnosis and Approaches to Treatment
Overactive Bladder: Diagnosis and Approaches to Treatment A Hidden Condition* Many Many patients self-manage by voiding frequently, reducing fluid intake, and wearing pads Nearly Nearly two-thirds thirds
More informationThe Development of the Revised Urinary Incontinence Scale (RUIS)
Mr Nick MAROSSZEKY J Sansoni 1, N Marosszeky 1, E Sansoni 1, G Hawthorne 2. 1 Australian Health Outcomes Collaboration, Centre for Health Service Development, University of Wollongong. 2 Department of
More informationIncontinence: Risks, Causes and Care
Welcome To Incontinence: Risks, Causes and Care Presented by Kamal Masaki, MD Professor and Chair Department of Geriatric Medicine John A. Burns School of Medicine, UH Manoa September 5, 2018 10:00 11:00
More informationMedical Review Criteria Invasive Treatment for Urinary Incontinence
Medical Review Criteria Invasive Treatment for Urinary Incontinence Effective Date: December 21, 2016 Subject: Invasive Treatment for Urinary Incontinence Background: Urinary incontinence (the involuntary
More informationTVT-O versus Monarc after a 2 4-year follow-up: a prospective comparative study
Int Urogynecol J (2009) 20:1327 1333 DOI 10.1007/s00192-009-0943-5 ORIGINAL ARTICLE TVT-O versus Monarc after a 2 4-year follow-up: a prospective comparative study R. Marijn Houwert & Charlotte Renes-Zijl
More informationUrogynecology in EDS. Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018
Urogynecology in EDS Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018 One in three like me Voiding Issues Frequency/Urgency Urinary Incontinence neurogenic bladder Neurologic supply
More informationMedical Policy Title: Radiofrequency ARBenefits Approval: 10/19/2011
Medical Policy Title: Radiofrequency ARBenefits Approval: 10/19/2011 Treatment, Urinary Stress Incontinence, Transurethral Effective Date: 01/01/2012 Document: ARB0359 Revision Date: Code(s): 53860 Transurethral
More informationSequential Assessment of Urodynamic Findings before and aftertension-free Vaginal Tape (TVT) Operation for Female Genuine Stress Incontinence
European Urology European Urology 45 (2004) 362 366 Sequential Assessment of Urodynamic Findings before and aftertension-free Vaginal Tape (TVT) Operation for Female Genuine Stress Incontinence Long-Yau
More informationA PATIENT GUIDE TO Understanding Stress Urinary Incontinence
A PATIENT GUIDE TO Understanding Stress Urinary Incontinence Q: What is SUI? A: Stress urinary incontinence is defined as the involuntary leakage of urine. The problem afflicts approximately 18 million
More informationIntraoperative Observation of the Degree and Pattern of Urine Leakage before Adjustment of the Mesh during a Transobturator Tape Procedure
Original Article www.cmj.ac.kr Intraoperative Observation of the Degree and Pattern of Urine Leakage before Adjustment of the Mesh during a Transobturator Tape Procedure Jae-Joon Park, Hyung Ho Lee 1 and
More informationSep \8958 Appell Dmochowski.ppt LMF 1
Surgical Outcomes (How did we get ourselves into this mess?) Roger R. Dmochowski, MD, FACS Department of Urologic Surgery Vanderbilt University School of Medicine Nashville, Tennessee Considerations Evaluation
More informationDiane K. Newman DNP, ANP-BC, PCB-PMD, FAAN
Diane K. Newman DNP, ANP-BC, PCB-PMD, FAAN Diane K. Newman, DNP is a Biofeedback Certified Continence Specialist. With over 35-years experience, she is an expert in the assessment and management of pelvic-floor
More informationLower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist
Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,
More informationThe Management of Female Urinary Incontinence. Part 1: Aetiology and Investigations
The Management of Female Urinary Incontinence Part 1: Aetiology and Investigations Dr Oseka Onuma Gynaecologist and Pelvic Reconstructive Surgeon 4 Robe Terrace Medindie SA 5081 Urinary incontinence has
More informationUrinary Incontinence for the Primary Care Provider
Urinary Incontinence for the Primary Care Provider Diana J Scott FNP-BC https://youtu.be/gmzaue1ojn4 1 Assessment of Urinary Incontinence Urge Stress Mixed Other overflow, postural, continuous, insensible,
More informationThe impact on health-related quality of life of stress, urge and mixed urinary incontinence
Original Article STRESS VS URGE INCONTINENCE K.S. COYNE et al. The impact on health-related quality of life of stress, urge and mixed urinary incontinence K.S. COYNE, Z. ZHOU*, C. THOMPSON and E. VERSI*
More informationTension-free Vaginal Tape for Urodynamic Stress Incontinence
Long-term Results of Tension-free Vaginal Tape Insertion for Urodynamic Stress Incontinence in Chinese Women at Eight-year Follow-up: a Prospective Study YM CHAN MBBS, MRCOG, FHKAM (O&G), DCG, DCH, DFM,
More informationSignal transduction underlying the control of urinary bladder smooth muscle tone Puspitoayu, E.
UvA-DARE (Digital Academic Repository) Signal transduction underlying the control of urinary bladder smooth muscle tone Puspitoayu, E. Link to publication Citation for published version (APA): Puspitoayu,
More informationMr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.
Mr. GIT KAH ANN Pakar Klinikal Urologi Hospital Kuala Lumpur drgitka@yahoo.com 25 Jan 2007 HIGHLIGHTS Introduction ICS Definition Making a Diagnosis Voiding Chart Investigation Urodynamics Ancillary Investigations
More informationLong-Term Outcome of the Tension-Free Vaginal Tape Procedure in Female Urinary Incontinence: A 6-Year Follow-Up
www.kjurology.org DOI:10.4111/kju.2010.51.6.409 Voiding Dysfunction Long-Term Outcome of the Tension-Free Vaginal Tape Procedure in Female Urinary Incontinence: A 6-Year Follow-Up Jun Hyung Lee, Min Chul
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Screening of Immediate Post Partum Females for Urinary Incontinence Ami Vishal Mehta 1, Zarna
More informationStudy Design SUIT was a longitudinal, observational, multicenter, 12-month study conducted in Germany, the UK, Sweden, and Ireland to
Volume 13 Number 1 2010 VALUE IN HEALTH Patient Characteristics Impacting Health State Index Scores, Measured by the EQ-5D of Females with Stress Urinary Incontinence Symptomsvhe_599 112..118 Douglas Tincello,
More informationA minimally invasive treatment for stress urinary incontinence
A minimally invasive treatment for stress urinary incontinence This booklet provides information about the Bulkamid hydrogel for the treatment of stress urinary incontinence What is stress urinary incontinence?
More informationPathophysiological Rationale for Surgical Treatments of Stress Urinary Incontinence
Pathophysiological Rationale for Surgical Treatments of Stress Urinary Incontinence Urology Grand Rounds April 6, 2005 Herman Christopher Kwan R4 A familiar case? 62 year old female initial presentation
More informationHelp-seeking and associated factors in female urinary incontinence The Norwegian EPINCONT Study
ORIGINAL PAPER Help-seeking and associated factors in female urinary incontinence The Norwegian EPINCONT Study Yngvild S. Hannestad, Guri Rortveit and Steinar Hunskaar Section for General Practice, Department
More informationA Simplified Urinary Incontinence Score for the Evaluation of Treatment Outcomes
Neurourology and Urodynamics 19:127 135 (2000) A Simplified Urinary Incontinence Score for the Evaluation of Treatment Outcomes Asnat Groutz, Jerry G. Blaivas,* and Jarrod E. Rosenthal Weill Medical College,
More informationUrinary incontinence in women
Urinary incontinence in women Lauren N Wood, 1 Jennifer T Anger 2 1 Cedars-Sinai Medical Center, Department of Surgery, Division of Urology, Los Angeles, CA, USA 2 Urologic Reconstruction, Urodynamics,
More informationBSUG Annual scientific update 5/6 th Nov 2012
BSUG Annual scientific update 5/6 th Nov 2012 Zainab Khan SWIG 4/12/2012 New developments in drug therapy B3 Agonists: Mirabegron - FDA approval - Mirabegron (50 &100mg) vs tolterodine 4mg- similar efficacy,
More informationq7:480499_P0 6/5/09 10:23 AM Page 1 WHAT YOU SHOULD KNOW ABOUT YOUR DIAGNOSIS OF STRESS URINARY INCONTINENCE
493495.q7:480499_P0 6/5/09 10:23 AM Page 1 WHAT YOU SHOULD KNOW ABOUT YOUR DIAGNOSIS OF STRESS URINARY INCONTINENCE 493495.q7:480499_P0 6/5/09 10:23 AM Page 2 What is Stress Urinary Incontinence? Urinary
More informationTable 1. International Consultation on Incontinence recommendations for frail older adults
Table 1. International Consultation on Incontinence recommendations for frail older adults Clinicians need to assess and manage co-existing co morbid conditions which are known to have an impact on continence
More informationEVALUATION OF STRESS URINARY INCONTINENCE: STATE-OF-THE-ART REVIEW
EVALUATION OF STRESS URINARY INCONTINENCE: STATE-OF-THE-ART REVIEW Dominic Lee, 1 *Philippe E. Zimmern 2 1. Department of Urology, St George Hospital, Kogarah, New South Wales, Australia 2. Department
More informationInjection of Urethral Bulking Agents
Injection of Urethral Bulking Agents Department of Gynaecology Patient Information What are urethral bulking agents? Urethral bulking agents are substances that are injected to support the bladder neck.
More informationFemale Urinary Incontinence: What It Is and What You Can Do About It
Female Urinary Incontinence: What It Is and What You Can Do About It Urogynecology Patient Information Sheet What is Urinary Incontinence? Stress Incontinence is a leakage of urine that occurs, for example,
More informationBen Herbert Alex Wojtowicz
Ben Herbert Alex Wojtowicz 54 year old female presenting with: Dragging sensation Urinary incontinence Some faecal incontinence HPC Since May 14 had noticed a mass protruding from the vagina when going
More informationUrinary Incontinence. Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital
Urinary Incontinence Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital Affects women of all ages Impacts physical, psychological & social wellbeing Impact on families & carers Costs the
More informationProlapse and Urogynae. By Sarah Rangan & Daniel Warrell
Prolapse and Urogynae By Sarah Rangan & Daniel Warrell Anatomy and physiology of the pelvic supports The pelvic floor supports the pelvic viscera and vaginal, urethral and rectal openings Endopelvic fascial
More information25-Feb-16 MANAGEMENT OF URINARY INCONTINENCE IN WOMEN.
Female Urinary Incontinence: GP resources MANAGEMENT OF URINARY INCONTINENCE IN WOMEN Dr Marcus Carey 20 February 2016 www.thewomens.org.au Clinical Practice Guidelines GP management of female urinary
More informationBrief involuntary urine loss associated with an increase in abdominal pressure. Pathophysiology of Stress Urinary Incontinence Edward J.
TREATMENT OF SUI Pathophysiology of Stress Urinary Incontinence Edward J. McGuire, MD Department of Urology, University of Michigan Medical Center, Ann Arbor, MI All cases of stress urinary incontinence
More informationPreferences for involvement in treatment decision-making among Norwegian women with urinary incontinence
Acta Obstetricia et Gynecologica. 2007; 86: 1370 1376 ORIGINAL ARTICLE Preferences for involvement in treatment decision-making among Norwegian women with urinary incontinence MÁIRE O DONNELL & STEINAR
More informationTaking Control of your Bladder, or. Don't make me laugh when laughter isn't the best medicine: a discussion on urinary incontinence
Taking Control of your Bladder, or Don't make me laugh when laughter isn't the best medicine: a discussion on urinary incontinence Brett Vassallo, MD, FACOG, FAC Female Pelvic Medicine and Reconstructive
More information